Pure Bioscience, Inc (PURE)

OTC Markets

Currency in USD

0.0736

0.0000(0.00%)

Closed·25/07

Fair Value

Unlock Value

Day's Range

0.0723

0.0750

52 wk Range

0.0450

0.2136

PURE Financial Summary

A brief financial summary of Pure Bioscience, Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-3.17

Price/Book-1.86

Debt / Equity-101.77%

Return on Equity81.12%

Dividend Yield0.00%

EBITDA-2.98M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/07

2016

31/07

2017

31/07

2018

31/07

2019

31/07

2020

31/07

2021

31/07

2022

31/07

2023

31/07

2024

31/07

Income Statement

Total Revenues

aa.aa

6.92

3.93

1.85

1.88

1.96

Gross Profit

aa.aa

4.02

2.08

0.97

1.15

Operating Income

aa.aa

-2.31

-3.37

-3.63

-3.13

Net Income

aa.aa

-2.32

-3.49

-3.96

-3.35

Balance Sheet

Total Assets

aa.aa

6.32

4.3

4.48

1.83

0.82

Total Current Liabilities

aa.aa

1.51

0.97

0.58

0.53

0.73

Total Equity

aa.aa

4.81

3.33

3.91

0.27

-2.86

Cash Flow

Levered Free Cash Flow

aa.aa

0.61

-0.82

-1.23

-1.95

-1.44

Cash from Operations

aa.aa

0.67

-1.17

-2.42

-3.28

-2.53

Cash from Investing

aa.aa

-0.06

-0.52

-0.08

-0.03

Cash from Financing

aa.aa

2.83

0.24

3.5

1.02

1.79

Net Change in Cash

aa.aa

3.44

-1.45

-2.3

-0.75

* In Millions of USD (except for per share items)

Earnings

Latest Release

Jun 16, 2025

EPS / Forecast

-0.02 / --

Revenue / Forecast

489.00K / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Pure Bioscience, Inc's earnings for the latest quarter?

The Pure Bioscience, Inc EPS (TTM) is -0.03. Pure Bioscience, Inc reported sales of 0.49, net income of -0.58, and EPS of -0.02 for the latest quarter.

What was Pure Bioscience, Inc's net income for the latest quarter?

Pure Bioscience, Inc's net income for the latest quarter was -0.58.

How did Pure Bioscience, Inc's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.39 in the previous quarter to 0.49 in the latest quarter, and net income moved from -0.80 to -0.58 compared to the previous quarter.

What is Pure Bioscience, Inc's net profit margin on a TTM basis?

Pure Bioscience, Inc's trailing twelve months (TTM) net profit margin is -170.66%.

How does Pure Bioscience, Inc's debt to equity ratio compare to industry standards?

Pure Bioscience, Inc's total debt-to-equity ratio is -101.77%.

What is Pure Bioscience, Inc's return on investment on a TTM basis?

Pure Bioscience, Inc's trailing twelve months (TTM) return on investment (ROI) is 81.12%.

Did Pure Bioscience, Inc gain or lose cash last quarter?

In the latest quarter, Pure Bioscience, Inc's net change in cash was 0.34 million.

What were Pure Bioscience, Inc's total assets and liabilities in the latest quarter?

As of the latest quarter, Pure Bioscience, Inc reported total assets of 1.06 million and total liabilities of 0.97 million.

How has Pure Bioscience, Inc's total revenue grown this year?

Pure Bioscience, Inc's total revenue was 0.39 in the previous quarter and 0.49 in the latest quarter.

What is Pure Bioscience, Inc's gross margin on a TTM basis?

Pure Bioscience, Inc's trailing twelve months (TTM) gross margin is 58.05%.

What was Pure Bioscience, Inc's revenue per share for the latest quarter?

Pure Bioscience, Inc's revenue per share for the latest quarter was 49.35.

NSE 30

4,954.07

+21.68

+0.44%

NSE All Share

135,166.52

+713.58

+0.53%

US 30

44,860.50

+22.9

+0.05%

US 500

6,395.10

+5.3

+0.08%

FTSE 100

9,081.44

-38.87

-0.43%

DAX

23,970.36

-247.14

-1.02%

South Africa Top 40

91,097.46

-205.94

-0.23%

Market Movers

Name	Last	Chg. %	Vol.
Fidelitybk	21.000	-0.94%	123.01M
Zenith Bank	72.70	-1.76%	31.03M
Nigerian Breweries	72.15	+0.07%	17.90M
Guaranty Trust Holding	94.10	+0.11%	15.61M
MTN Nigeria	410.60	+2.65%	4.03M
Dangote Cement	494.50	+0.30%	3.00M
Okomu Oil Palm	1,000.00	+0.20%	1.59M

Name	Last	Chg. %	Vol.
Academy Press	10.24	+9.99%	4.21M
Champion Brew	13.55	+9.98%	2.86M
Tripple Gee and Co	3.86	+9.97%	496.81K
Maybaker	18.800	+9.94%	2.75M
UAC Of Nigeria	60.40	+9.92%	800.98K
UPDC REIT	9.45	+9.88%	3.46M
Daarcomm	0.89	+9.88%	7.11M

Name	Last	Chg. %	Vol.
Livestock	8.10	-10.00%	8.04M
Initiates	14.52	-9.98%	7.02M
Ellah Lakes	8.91	-9.08%	25.22M
Nigerian Exchange	75.00	-6.02%	2.43M
Thomaswy	2.90	-5.54%	715.17K
Afriprud	15.40	-4.94%	4.66M
Cutix	3.900	-4.88%	15.17M

Trending Stocks

Name	Last	Chg. %	Vol.
Initiates	14.52	-9.98%	7.02M
Okomu Oil Palm	1,000.00	+0.20%	1.59M
Aradel Holdings	507.00	0.00%	1.47M
Access Holdings	27.30	-1.44%	29.06M
BUA Cement	135.00	0.00%	2.01M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaa	66.50	+36.34%	90.67
Aaaaaaaa A	5,450.00	+34.44%	7,326.98
Aaaaaaaaaaaaaaaa Aaa	494.50	+30.75%	646.56
Aaaaa Aaa A	135.00	+21.85%	164.50

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Pure Bioscience, Inc (PURE)

PURE Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Pure Bioscience, Inc's earnings for the latest quarter?

What was Pure Bioscience, Inc's net income for the latest quarter?

How did Pure Bioscience, Inc's performance compare year-over-year in the latest quarter?

What is Pure Bioscience, Inc's net profit margin on a TTM basis?

How does Pure Bioscience, Inc's debt to equity ratio compare to industry standards?

What is Pure Bioscience, Inc's return on investment on a TTM basis?

Did Pure Bioscience, Inc gain or lose cash last quarter?

What were Pure Bioscience, Inc's total assets and liabilities in the latest quarter?

How has Pure Bioscience, Inc's total revenue grown this year?

What is Pure Bioscience, Inc's gross margin on a TTM basis?

What was Pure Bioscience, Inc's revenue per share for the latest quarter?

Trending Stocks